Skip to content
  • About
  • Contact
  • Contribute
  • What Physicians Say
  • My Book
  • Careers
  • Podcast
  • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
  • About Kevin Pho, MD, Founder of KevinMD
  • Aging and dementia: what physicians say, in their own words
  • Artificial intelligence: what physicians say, in their own words
  • Be heard on social media’s leading physician voice
  • Cancer: what physicians say, in their own words
  • Children’s health: what pediatricians say, in their own words
  • Contact Kevin
  • COVID-19: what physicians wrote as it happened
  • Custom enhanced author page pricing
  • Diabetes and obesity: what physicians say, in their own words
  • Direct primary care: what physicians say, in their own words
  • DMCA Policy
  • End of life: what physicians say, in their own words
  • Establishing, Managing, and Protecting Your Online Reputation: A Social Media Guide for Physicians and Medical Practices
  • GLP-1 drugs: what physicians say about Ozempic and its successors, in their own words
  • Heart disease: what physicians say, in their own words
  • Immigration and medicine: what physicians say about immigrant doctors and immigrant patients, in their own words
  • KevinMD influencer opportunities
  • Medical errors: what physicians say, in their own words
  • Medical ethics: what physicians say, in their own words
  • Medical malpractice: what physicians say, in their own words
  • Medical school: what students and physicians say, in their own words
  • Mental health: what psychiatrists and physicians say, in their own words
  • Nursing: what nurses and physicians say, in their own words
  • Opinion and commentary by KevinMD
  • Opioids: what physicians and pain patients say, in their own words
  • Physician burnout speakers to keynote your conference
  • Physician burnout: what physicians say, in their own words
  • Physician Coaching by KevinMD
  • Physician keynote speaker: Kevin Pho, MD
  • Physician personal finance: what physicians say about their own money, in their own words
  • Physician Speaking by KevinMD: a boutique speakers bureau
  • Physician suicide: what physicians say, in their own words
  • Physicians and administrators: what physicians say about who runs medicine, in their own words
  • Primary care physician in Nashua, NH | Kevin Pho, MD
  • Primary care: what physicians say, in their own words
  • Prior authorization: what physicians say, in their own words
  • Privacy Policy
  • Private equity and corporate medicine: what physicians say, in their own words
  • Race and medicine: what physicians say, in their own words
  • Recommended services by KevinMD
  • Residency: what residents and attendings say, in their own words
  • Scope of practice: what physicians, nurse practitioners, and PAs say, in their own words
  • Subscribe to the KevinMD enhanced author page
  • Subscribe to the newsletter
  • Surgeons and surgery: what surgeons say, in their own words
  • Take-home messages: what physicians say when asked to leave one
  • Terms of Use Agreement
  • Thank you for subscribing to KevinMD
  • Thank you for upgrading to the KevinMD enhanced author page
  • The electronic health record: what physicians say, in their own words
  • Vaccines: what physicians say, in their own words
  • Violence against health care workers: what physicians and nurses say, in their own words
  • What physicians say: the KevinMD records
  • Women in medicine: what women physicians say, in their own words
  • Women’s health: what physicians say, in their own words

Are we underestimating the danger of prions and prion based diseases?

Robert Trent
Conditions and Diseases
January 27, 2021
Share
Tweet
Share

Assessment without definition: a flat tire on the road of progress

Even though we have known about prions for decades, very little progress has been made in defining what a prion is vs. what a prion is not, how they get into the brain, and how prion diseases are different from other neurodegenerative diseases. Phenomenologically these definitions can vary widely. To some, a prion causes a deadly, untestable (in clinical practice), and incurable neurodegenerative disease. To others, a prion is what forms long-term memories. To others still, a prion is what causes anti-fungal resistance and allows life forms to evolve in new environments.

This wide range of variation in how we define what a prion is vs. what a prion does not leads to unproductive conversations among professionals working in relevant fields of study. Subsequently, unproductive conversations lead to delays in scientific progress. I have personally witnessed very well educated individuals talking past each other solely because of poorly established definitions. I believe that we can, and absolutely should, do better in guiding our discussions and research on prions and prion based diseases by establishing a well understood standardized definition. I also believe that this poor definition is putting health care workers and researchers alike at risk for unnecessary exposure.

Without a working definition of what a prion is and what prion based diseases are, we are left unable to assess the risk associated with them. There is evidence that Alzheimer’s is an infectious prion disease. Descriptively, Alzheimer’s has many similarities with Parkinson’s, schizophrenia, and many other diseases.  Since we are mostly using phenomenological definitions of what constitutes a prion, Alzheimer’s and other prion diseases end up becoming undifferentiable, and therefore we cannot say with certainty that Alzheimer’s is not a prion disease.

When we look at the alarmingly high rates of hepatitis C among the elderly that was caused by improper instrument sterilization and not by the drug friendly promiscuous lifestyle of the 60s. One has to consider if the current Alzheimer epidemic has been caused by prion-based diseases acquired from poor surgical sterilization in the 50s. The impact of the Alzheimer’s epidemic has been incredibly severe and more work needs to be done in order to fully understand cause, effect, and then prevention.

Proactive not reactive

Science does not make outright claims that events will either happen or not, but merely ascribes the probability of an event happening based on the initial conditions. Since everything that makes up Cells, organs, and organisms is exponentially dependent on initial conditions, we can’t make definite predictions on large scale events.

This leads me to my next point: I am advocating that we invoke a proactive, rather than reactive stance that Alzheimer’s and other neurodegenerative diseases are infectious prion-based diseases.

This implies that when handling nervous tissue, we should act under the assumption that the nervous tissue contains hitherto unknown infectious prions, even if there are no indicators that this is the case. Nervous tissue is often handled at biosafety level 2 (BSL2). However, most infectious prions (that are known of) are assigned to a biosafety level of 3 (BSL3). When I worked in diagnostics, no testing was ever done on nervous tissue to see if prions were present or not. Given the exceedingly long time it takes for prion-based diseases to cross a threshold of pathology whereby the infection becomes detectable to a clinician, we cannot rely on epidemiological data to ensure health care workers’ safety, we must be proactive and precautious in our actions and not reactive.

Pascal’s wager and gun safety

If you have ever taken a hunter’s education course on gun safety, you will have witnessed an example of Pascal’s wager being applied. The first rule of gun safety is to assume that any gun is loaded and can go off at any time. When carrying a gun, it should always be pointed at the ground and away from anything that might be damaged or injured should the gun go off and fire. These rules are applied and carried out by any responsible gun owner even when they know that the gun is not loaded and that the safety is on. Despite the fact that there is virtually no possible way that the gun could fire a live round, the responsible course of action is to act as if the gun could go off at any time. This paranoid course of action is utilized because the severity of the outcome whereby the gun fires and kills someone is so large that even if the odds are small, the outcome is significant, should the unlikely event occur. This is exactly the approach we should be taking towards handling nervous tissue, prions, and prion based diseases. Pathologists, cytotechnologists, medical school anatomy labs, and etc., should be operating under BSL3 precautions when handling nervous tissue, not BSL2.

Robert Trent is a graduate student.

Image credit: Shutterstock.com

Prev

A surgeon left his own son's funeral to take care of your child

January 27, 2021 Kevin 7
…
Next

14 tips when negotiating a physician job

January 27, 2021 Kevin 0
…

ADVERTISEMENT

Tagged as: Neurology

< Previous Post
A surgeon left his own son's funeral to take care of your child
Next Post >
14 tips when negotiating a physician job

 

ADVERTISEMENT

More by Robert Trent

  • Why standardized medical exams filter for compliant workers

    Robert Trent
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • Does the FDA approval of aducanumab mark the return of science-based medicine?

    Robert Trent

Related Posts

  • The expanding role of specialists in value-based care

    Martin Lustick, MD
  • Lessons from the meeting of different value-based concepts

    Joshua Liao, MD
  • Behavioral health providers face challenges in value-based care

    Martin Lustick, MD
  • In crisis, danger and opportunity are present

    Casey P. Schukow, DO
  • Considering the recent setbacks of evidence-based medicine

    Kenneth Lin, MD
  • Market-based approaches solving the opioid epidemic

    Julie Craig, MD

More in Conditions and Diseases

  • Shift work and circadian rhythms shape the 24/7 workplace

    Deepak Gupta, MD
  • Telehealth and postpartum psychosis defy simple blame

    Rabia Cheema, MD
  • Underage online gambling needs more than a checkbox

    Kayvan Haddadan, MD
  • Why must fourth trimester care begin after delivery?

    Allison P. Boyle, DPA, PA-C
  • Nutrition during cancer treatment is more than calories

    Dr. Manjari Chandra
  • Why witnessing death outside the hospital felt different

    Denise Moulton, RN
  • Most Popular

  • Past Week

    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications
    • Surgical judgment: the skill no one sees from the gallery

      Mustafa Kemal Çalık, MD | Physician
    • Why haven’t ambient AI scribes boosted productivity?

      Karan Kanwar | Health Technology
    • Physician well-being is not an individual problem

      Heather Buckley | Conditions and Diseases
    • Burnout isn’t only about autonomy, it’s about your bank account [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • Shift work and circadian rhythms shape the 24/7 workplace

      Deepak Gupta, MD | Conditions and Diseases
    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • The next child

      Medicaid managed care and the case for mutual stewardship

      Steven Merahn, MD | Health Policy
    • Choosing a limb lengthening surgeon requires accountability

      Hrayr Basmajian, MD | Physician
    • Cited but never checked

      Why AI crisis advice may fail families facing psychosis

      Nicole Drapeau Gillen | Health Technology
    • How AI phone systems in health care create barriers

      Thuy D. Bui, MD | Health Technology

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications
    • Surgical judgment: the skill no one sees from the gallery

      Mustafa Kemal Çalık, MD | Physician
    • Why haven’t ambient AI scribes boosted productivity?

      Karan Kanwar | Health Technology
    • Physician well-being is not an individual problem

      Heather Buckley | Conditions and Diseases
    • Burnout isn’t only about autonomy, it’s about your bank account [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • Shift work and circadian rhythms shape the 24/7 workplace

      Deepak Gupta, MD | Conditions and Diseases
    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • The next child

      Medicaid managed care and the case for mutual stewardship

      Steven Merahn, MD | Health Policy
    • Choosing a limb lengthening surgeon requires accountability

      Hrayr Basmajian, MD | Physician
    • Cited but never checked

      Why AI crisis advice may fail families facing psychosis

      Nicole Drapeau Gillen | Health Technology
    • How AI phone systems in health care create barriers

      Thuy D. Bui, MD | Health Technology

Copyright © 2026 KevinMD.com | Powered by Astra WordPress Theme

  • Terms of Use Agreement
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...